Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 181

1.

Genomic structure and diversity of Plasmodium falciparum in Southeast Asia reveal recent parasite migration patterns.

Shetty AC, Jacob CG, Huang F, Li Y, Agrawal S, Saunders DL, Lon C, Fukuda MM, Ringwald P, Ashley EA, Han KT, Hlaing TM, Nyunt MM, Silva JC, Stewart KE, Plowe CV, O'Connor TD, Takala-Harrison S; Artemisinin Resistance Confirmation, Characterization, and Containment (ARC3); Artemisinin Resistance Containment and Elimination (ARCE); Tracking Resistance to Artemisinin Collaboration (TRAC).

Nat Commun. 2019 Jun 17;10(1):2665. doi: 10.1038/s41467-019-10121-3.

PMID:
31209259
2.

More on Artemisinin-Resistant Plasmodium falciparum in Eastern India.

Rasmussen C, Valecha N, Ringwald P.

N Engl J Med. 2019 Mar 14;380(11):e14. doi: 10.1056/NEJMc1817141. No abstract available.

PMID:
30865817
3.

Lack of convincing evidence of artemisinin resistance in India.

Rasmussen C, Valecha N, Ringwald P.

Clin Infect Dis. 2019 Feb 28. pii: ciz166. doi: 10.1093/cid/ciz166. [Epub ahead of print] No abstract available.

PMID:
30820524
4.

Efficacy and Safety of Pyronaridine-Artesunate plus Single-Dose Primaquine for Treatment of Uncomplicated Plasmodium falciparum Malaria in Eastern Cambodia.

Leang R, Mairet-Khedim M, Chea H, Huy R, Khim N, Mey Bouth D, Dorina Bustos M, Ringwald P, Witkowski B.

Antimicrob Agents Chemother. 2019 Feb 26;63(3). pii: e02242-18. doi: 10.1128/AAC.02242-18. Print 2019 Mar.

PMID:
30602520
5.

Prevalence of molecular markers of artemisinin and lumefantrine resistance among patients with uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2015.

Ljolje D, Dimbu PR, Kelley J, Goldman I, Nace D, Macaia A, Halsey ES, Ringwald P, Fortes F, Udhayakumar V, Talundzic E, Lucchi NW, Plucinski MM.

Malar J. 2018 Feb 20;17(1):84. doi: 10.1186/s12936-018-2233-5.

6.

Drug-Resistant Polymorphisms and Copy Numbers in Plasmodium falciparum, Mozambique, 2015.

Gupta H, Macete E, Bulo H, Salvador C, Warsame M, Carvalho E, Ménard D, Ringwald P, Bassat Q, Enosse S, Mayor A.

Emerg Infect Dis. 2018 Jan;24(1):40-48. doi: 10.3201/eid2401.170864.

7.

Response of imported malaria patients to antimalarial medicines in Sri Lanka following malaria elimination.

Dharmawardena P, Rodrigo C, Mendis K, de A W Gunasekera WMKT, Premaratne R, Ringwald P, Fernando D.

PLoS One. 2017 Nov 28;12(11):e0188613. doi: 10.1371/journal.pone.0188613. eCollection 2017.

8.

Population Pharmacokinetic and Pharmacodynamic Modeling of Artemisinin Resistance in Southeast Asia.

Lohy Das J, Dondorp AM, Nosten F, Phyo AP, Hanpithakpong W, Ringwald P, Lim P, White NJ, Karlsson MO, Bergstrand M, Tarning J.

AAPS J. 2017 Nov;19(6):1842-1854. doi: 10.1208/s12248-017-0141-1. Epub 2017 Sep 11.

PMID:
28895080
9.

Clinical and molecular surveillance of artemisinin resistant falciparum malaria in Myanmar (2009-2013).

Nyunt MH, Soe MT, Myint HW, Oo HW, Aye MM, Han SS, Zaw NN, Cho C, Aung PZ, Kyaw KT, Aye TT, San NA, Ortega L, Thimasarn K, Bustos MDG, Galit S, Hoque MR, Ringwald P, Han ET, Kyaw MP.

Malar J. 2017 Aug 14;16(1):333. doi: 10.1186/s12936-017-1983-9.

10.

Artemisinin-Resistant Plasmodium falciparum in Africa.

Rasmussen C, Nyunt MM, Ringwald P.

N Engl J Med. 2017 Jul 20;377(3):305-306. doi: 10.1056/NEJMc1705789. No abstract available.

PMID:
28723327
11.

Chloroquine efficacy for Plasmodium vivax in Myanmar in populations with high genetic diversity and moderate parasite gene flow.

Htun MW, Mon NCN, Aye KM, Hlaing CM, Kyaw MP, Handayuni I, Trimarsanto H, Bustos D, Ringwald P, Price RN, Auburn S, Thriemer K.

Malar J. 2017 Jul 10;16(1):281. doi: 10.1186/s12936-017-1912-y.

12.

Therapeutic efficacy and artemisinin resistance in northern Myanmar: evidence from in vivo and molecular marker studies.

Myint MK, Rasmussen C, Thi A, Bustos D, Ringwald P, Lin K.

Malar J. 2017 Apr 7;16(1):143. doi: 10.1186/s12936-017-1775-2.

13.

Treatment Failure of Dihydroartemisinin/Piperaquine for Plasmodium falciparum Malaria, Vietnam.

Phuc BQ, Rasmussen C, Duong TT, Dong LT, Loi MA, Ménard D, Tarning J, Bustos D, Ringwald P, Galappaththy GL, Thieu NQ.

Emerg Infect Dis. 2017 Apr;23(4):715-717. doi: 10.3201/eid2304.161872.

14.

Efficacy of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015.

Plucinski MM, Dimbu PR, Macaia AP, Ferreira CM, Samutondo C, Quivinja J, Afonso M, Kiniffo R, Mbounga E, Kelley JS, Patel DS, He Y, Talundzic E, Garrett DO, Halsey ES, Udhayakumar V, Ringwald P, Fortes F.

Malar J. 2017 Feb 2;16(1):62. doi: 10.1186/s12936-017-1712-4.

15.

Emerging polymorphisms in falciparum Kelch 13 gene in Northeastern region of India.

Mishra N, Bharti RS, Mallick P, Singh OP, Srivastava B, Rana R, Phookan S, Gupta HP, Ringwald P, Valecha N.

Malar J. 2016 Dec 3;15(1):583.

16.

A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study.

Witkowski B, Duru V, Khim N, Ross LS, Saintpierre B, Beghain J, Chy S, Kim S, Ke S, Kloeung N, Eam R, Khean C, Ken M, Loch K, Bouillon A, Domergue A, Ma L, Bouchier C, Leang R, Huy R, Nuel G, Barale JC, Legrand E, Ringwald P, Fidock DA, Mercereau-Puijalon O, Ariey F, Ménard D.

Lancet Infect Dis. 2017 Feb;17(2):174-183. doi: 10.1016/S1473-3099(16)30415-7. Epub 2016 Nov 3. Erratum in: Lancet Infect Dis. 2018 Aug;18(8):829.

17.

Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria from three highly malarious states in India.

Bharti PK, Shukla MM, Ringwald P, Krishna S, Singh PP, Yadav A, Mishra S, Gahlot U, Malaiya JP, Kumar A, Prasad S, Baghel P, Singh M, Vadadi J, Singh MP, Bustos MD, Ortega LI, Christophel EM, Kashyotia SS, Sonal GS, Singh N.

Malar J. 2016 Oct 13;15(1):498.

18.

Continued Sensitivity of Plasmodium falciparum to Artemisinin in Guyana, With Absence of Kelch Propeller Domain Mutant Alleles.

Rahman R, Martin MJ, Persaud S, Ceron N, Kellman D, Musset L, Carter KH, Ringwald P.

Open Forum Infect Dis. 2016 Aug 30;3(3):ofw185. eCollection 2016 Sep.

19.

Role of K13 Mutations in Artemisinin-Based Combination Therapy.

Rasmussen C, Ariey F, Fairhurst RM, Ringwald P, Ménard D.

Clin Infect Dis. 2016 Dec 15;63(12):1680-1681. Epub 2016 Sep 22. No abstract available.

20.

Therapeutic efficacy trial of artemisinin-based combination therapy for the treatment of uncomplicated malaria and investigation of mutations in k13 propeller domain in Togo, 2012-2013.

Dorkenoo AM, Yehadji D, Agbo YM, Layibo Y, Agbeko F, Adjeloh P, Yakpa K, Sossou E, Awokou F, Ringwald P.

Malar J. 2016 Jun 22;15:331. doi: 10.1186/s12936-016-1381-8.

21.

A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms.

Ménard D, Khim N, Beghain J, Adegnika AA, Shafiul-Alam M, Amodu O, Rahim-Awab G, Barnadas C, Berry A, Boum Y, Bustos MD, Cao J, Chen JH, Collet L, Cui L, Thakur GD, Dieye A, Djallé D, Dorkenoo MA, Eboumbou-Moukoko CE, Espino FE, Fandeur T, Ferreira-da-Cruz MF, Fola AA, Fuehrer HP, Hassan AM, Herrera S, Hongvanthong B, Houzé S, Ibrahim ML, Jahirul-Karim M, Jiang L, Kano S, Ali-Khan W, Khanthavong M, Kremsner PG, Lacerda M, Leang R, Leelawong M, Li M, Lin K, Mazarati JB, Ménard S, Morlais I, Muhindo-Mavoko H, Musset L, Na-Bangchang K, Nambozi M, Niaré K, Noedl H, Ouédraogo JB, Pillai DR, Pradines B, Quang-Phuc B, Ramharter M, Randrianarivelojosia M, Sattabongkot J, Sheikh-Omar A, Silué KD, Sirima SB, Sutherland C, Syafruddin D, Tahar R, Tang LH, Touré OA, Tshibangu-wa-Tshibangu P, Vigan-Womas I, Warsame M, Wini L, Zakeri S, Kim S, Eam R, Berne L, Khean C, Chy S, Ken M, Loch K, Canier L, Duru V, Legrand E, Barale JC, Stokes B, Straimer J, Witkowski B, Fidock DA, Rogier C, Ringwald P, Ariey F, Mercereau-Puijalon O; KARMA Consortium.

N Engl J Med. 2016 Jun 23;374(25):2453-64. doi: 10.1056/NEJMoa1513137.

22.

Efficacy and Safety of Pyronaridine-Artesunate for Treatment of Uncomplicated Plasmodium falciparum Malaria in Western Cambodia.

Leang R, Canavati SE, Khim N, Vestergaard LS, Borghini Fuhrer I, Kim S, Denis MB, Heng P, Tol B, Huy R, Duparc S, Dondorp AM, Menard D, Ringwald P.

Antimicrob Agents Chemother. 2016 Jun 20;60(7):3884-90. doi: 10.1128/AAC.00039-16. Print 2016 Jul.

23.

In Vivo Efficacy and Parasite Clearance of Artesunate + Sulfadoxine-Pyrimethamine Versus Artemether-Lumefantrine in Mali.

Niaré K, Dara A, Sagara I, Sissoko MS, Guindo CO, Cissé NH, Coulibaly CO, Ringwald P, Benoit-Vical F, Berry A, Djimdé AA, Doumbo OK.

Am J Trop Med Hyg. 2016 Mar;94(3):634-9. doi: 10.4269/ajtmh.15-0503. Epub 2016 Jan 25.

24.

Ethical aspects of malaria control and research.

Jamrozik E, de la Fuente-Núñez V, Reis A, Ringwald P, Selgelid MJ.

Malar J. 2015 Dec 22;14:518. doi: 10.1186/s12936-015-1042-3. Review.

25.

Artemisinin resistance in Myanmar.

Plowe CV, Ringwald P.

Lancet Infect Dis. 2015 Sep;15(9):1001-1002. doi: 10.1016/S1473-3099(15)00232-7. No abstract available.

PMID:
26333324
26.

Tolerability and safety of weekly primaquine against relapse of Plasmodium vivax in Cambodians with glucose-6-phosphate dehydrogenase deficiency.

Kheng S, Muth S, Taylor WR, Tops N, Kosal K, Sothea K, Souy P, Kim S, Char CM, Vanna C, Ly P, Ringwald P, Khieu V, Kerleguer A, Tor P, Baird JK, Bjorge S, Menard D, Christophel E.

BMC Med. 2015 Aug 25;13:203. doi: 10.1186/s12916-015-0441-1.

27.

Severe Malaria Not Responsive to Artemisinin Derivatives in Man Returning from Angola to Vietnam.

Ringwald P, Dondorp AM.

Emerg Infect Dis. 2015 Jul;21(7):1264-5. doi: 10.3201/eid2107.141448. No abstract available.

28.

Evidence of Plasmodium falciparum Malaria Multidrug Resistance to Artemisinin and Piperaquine in Western Cambodia: Dihydroartemisinin-Piperaquine Open-Label Multicenter Clinical Assessment.

Leang R, Taylor WR, Bouth DM, Song L, Tarning J, Char MC, Kim S, Witkowski B, Duru V, Domergue A, Khim N, Ringwald P, Menard D.

Antimicrob Agents Chemother. 2015 Aug;59(8):4719-26. doi: 10.1128/AAC.00835-15. Epub 2015 May 26.

29.

A Single Mutation in K13 Predominates in Southern China and Is Associated With Delayed Clearance of Plasmodium falciparum Following Artemisinin Treatment.

Huang F, Takala-Harrison S, Jacob CG, Liu H, Sun X, Yang H, Nyunt MM, Adams M, Zhou S, Xia Z, Ringwald P, Bustos MD, Tang L, Plowe CV.

J Infect Dis. 2015 Nov 15;212(10):1629-35. doi: 10.1093/infdis/jiv249. Epub 2015 Apr 24.

30.

Efficacy of chloroquine for the treatment of Plasmodium vivax in the Saharan zone in Mauritania.

Ould Ahmedou Salem MS, Mohamed Lemine YO, Deida JM, Lemrabott MA, Ouldabdallahi M, Ba MD, Boukhary AO, Khairy ML, Abdel Aziz MB, Ringwald P, Basco LK, Niang SD, Lebatt SM.

Malar J. 2015 Jan 28;14:39. doi: 10.1186/s12936-015-0563-0.

31.

Genetic architecture of artemisinin-resistant Plasmodium falciparum.

Miotto O, Amato R, Ashley EA, MacInnis B, Almagro-Garcia J, Amaratunga C, Lim P, Mead D, Oyola SO, Dhorda M, Imwong M, Woodrow C, Manske M, Stalker J, Drury E, Campino S, Amenga-Etego L, Thanh TN, Tran HT, Ringwald P, Bethell D, Nosten F, Phyo AP, Pukrittayakamee S, Chotivanich K, Chuor CM, Nguon C, Suon S, Sreng S, Newton PN, Mayxay M, Khanthavong M, Hongvanthong B, Htut Y, Han KT, Kyaw MP, Faiz MA, Fanello CI, Onyamboko M, Mokuolu OA, Jacob CG, Takala-Harrison S, Plowe CV, Day NP, Dondorp AM, Spencer CC, McVean G, Fairhurst RM, White NJ, Kwiatkowski DP.

Nat Genet. 2015 Mar;47(3):226-34. doi: 10.1038/ng.3189. Epub 2015 Jan 19.

32.

Efficacy of artesunate-amodiaquine for the treatment of acute uncomplicated falciparum malaria in southern Mauritania.

Ouldabdallahi M, Alew I, Salem MS, Dit Dialaw Ba M, Boukhary AO, Khairy ML, Aziz MB, Ringwald P, Basco LK, Niang SD, Lebatt SM.

Malar J. 2014 Dec 16;13:496. doi: 10.1186/1475-2875-13-496.

33.

Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia.

Takala-Harrison S, Jacob CG, Arze C, Cummings MP, Silva JC, Dondorp AM, Fukuda MM, Hien TT, Mayxay M, Noedl H, Nosten F, Kyaw MP, Nhien NT, Imwong M, Bethell D, Se Y, Lon C, Tyner SD, Saunders DL, Ariey F, Mercereau-Puijalon O, Menard D, Newton PN, Khanthavong M, Hongvanthong B, Starzengruber P, Fuehrer HP, Swoboda P, Khan WA, Phyo AP, Nyunt MM, Nyunt MH, Brown TS, Adams M, Pepin CS, Bailey J, Tan JC, Ferdig MT, Clark TG, Miotto O, MacInnis B, Kwiatkowski DP, White NJ, Ringwald P, Plowe CV.

J Infect Dis. 2015 Mar 1;211(5):670-9. doi: 10.1093/infdis/jiu491. Epub 2014 Sep 1.

34.

Molecular surveillance for artemisinin resistance in Africa.

Roper C, Alifrangis M, Ariey F, Talisuna A, Menard D, Mercereau-Puijalon O, Ringwald P.

Lancet Infect Dis. 2014 Aug;14(8):668-670. doi: 10.1016/S1473-3099(14)70826-6. No abstract available.

PMID:
25056012
35.

Evaluation of community-based systems for the surveillance of day three-positive Plasmodium falciparum cases in Western Cambodia.

Cox J, Dy Soley L, Bunkea T, Sovannaroth S, Soy Ty K, Ngak S, Bjorge S, Ringwald P, Mellor S, Sintasath D, Meek S.

Malar J. 2014 Jul 22;13:282. doi: 10.1186/1475-2875-13-282.

36.

A molecular marker of artemisinin-resistant Plasmodium falciparum malaria.

Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, Kim S, Duru V, Bouchier C, Ma L, Lim P, Leang R, Duong S, Sreng S, Suon S, Chuor CM, Bout DM, Ménard S, Rogers WO, Genton B, Fandeur T, Miotto O, Ringwald P, Le Bras J, Berry A, Barale JC, Fairhurst RM, Benoit-Vical F, Mercereau-Puijalon O, Ménard D.

Nature. 2014 Jan 2;505(7481):50-5. doi: 10.1038/nature12876. Epub 2013 Dec 18.

37.

Artemisinin resistance is a clear and present danger.

Dondorp AM, Ringwald P.

Trends Parasitol. 2013 Aug;29(8):359-60. doi: 10.1016/j.pt.2013.05.005. Epub 2013 Jun 12. No abstract available.

PMID:
23768981
38.

Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia.

Miotto O, Almagro-Garcia J, Manske M, Macinnis B, Campino S, Rockett KA, Amaratunga C, Lim P, Suon S, Sreng S, Anderson JM, Duong S, Nguon C, Chuor CM, Saunders D, Se Y, Lon C, Fukuda MM, Amenga-Etego L, Hodgson AV, Asoala V, Imwong M, Takala-Harrison S, Nosten F, Su XZ, Ringwald P, Ariey F, Dolecek C, Hien TT, Boni MF, Thai CQ, Amambua-Ngwa A, Conway DJ, Djimdé AA, Doumbo OK, Zongo I, Ouedraogo JB, Alcock D, Drury E, Auburn S, Koch O, Sanders M, Hubbart C, Maslen G, Ruano-Rubio V, Jyothi D, Miles A, O'Brien J, Gamble C, Oyola SO, Rayner JC, Newbold CI, Berriman M, Spencer CC, McVean G, Day NP, White NJ, Bethell D, Dondorp AM, Plowe CV, Fairhurst RM, Kwiatkowski DP.

Nat Genet. 2013 Jun;45(6):648-55. doi: 10.1038/ng.2624. Epub 2013 Apr 28.

39.

Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar.

Kyaw MP, Nyunt MH, Chit K, Aye MM, Aye KH, Aye MM, Lindegardh N, Tarning J, Imwong M, Jacob CG, Rasmussen C, Perin J, Ringwald P, Nyunt MM.

PLoS One. 2013;8(3):e57689. doi: 10.1371/journal.pone.0057689. Epub 2013 Mar 8.

40.

Current status of artemisinin-resistant falciparum malaria in South Asia: a randomized controlled artesunate monotherapy trial in Bangladesh.

Starzengruber P, Swoboda P, Fuehrer HP, Khan WA, Hofecker V, Siedl A, Fally M, Graf O, Teja-Isavadharm P, Haque R, Ringwald P, Noedl H.

PLoS One. 2012;7(12):e52236. doi: 10.1371/journal.pone.0052236. Epub 2012 Dec 18.

41.

Genetic loci associated with delayed clearance of Plasmodium falciparum following artemisinin treatment in Southeast Asia.

Takala-Harrison S, Clark TG, Jacob CG, Cummings MP, Miotto O, Dondorp AM, Fukuda MM, Nosten F, Noedl H, Imwong M, Bethell D, Se Y, Lon C, Tyner SD, Saunders DL, Socheat D, Ariey F, Phyo AP, Starzengruber P, Fuehrer HP, Swoboda P, Stepniewska K, Flegg J, Arze C, Cerqueira GC, Silva JC, Ricklefs SM, Porcella SF, Stephens RM, Adams M, Kenefic LJ, Campino S, Auburn S, MacInnis B, Kwiatkowski DP, Su XZ, White NJ, Ringwald P, Plowe CV.

Proc Natl Acad Sci U S A. 2013 Jan 2;110(1):240-5. doi: 10.1073/pnas.1211205110. Epub 2012 Dec 17.

42.

Efficacy of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, 2008 to 2010.

Leang R, Barrette A, Bouth DM, Menard D, Abdur R, Duong S, Ringwald P.

Antimicrob Agents Chemother. 2013 Feb;57(2):818-26. doi: 10.1128/AAC.00686-12. Epub 2012 Dec 3.

43.

Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in western Cambodia.

Witkowski B, Khim N, Chim P, Kim S, Ke S, Kloeung N, Chy S, Duong S, Leang R, Ringwald P, Dondorp AM, Tripura R, Benoit-Vical F, Berry A, Gorgette O, Ariey F, Barale JC, Mercereau-Puijalon O, Menard D.

Antimicrob Agents Chemother. 2013 Feb;57(2):914-23. doi: 10.1128/AAC.01868-12. Epub 2012 Dec 3.

44.

Effect of high-dose or split-dose artesunate on parasite clearance in artemisinin-resistant falciparum malaria.

Das D, Tripura R, Phyo AP, Lwin KM, Tarning J, Lee SJ, Hanpithakpong W, Stepniewska K, Menard D, Ringwald P, Silamut K, Imwong M, Chotivanich K, Yi P, Day NP, Lindegardh N, Socheat D, Nguon C, White NJ, Nosten F, Dondorp AM.

Clin Infect Dis. 2013 Mar;56(5):e48-58. doi: 10.1093/cid/cis958. Epub 2012 Nov 21.

45.

In vivo susceptibility of Plasmodium falciparum to artesunate in Binh Phuoc Province, Vietnam.

Hien TT, Thuy-Nhien NT, Phu NH, Boni MF, Thanh NV, Nha-Ca NT, Thai le H, Thai CQ, Toi PV, Thuan PD, Long le T, Dong le T, Merson L, Dolecek C, Stepniewska K, Ringwald P, White NJ, Farrar J, Wolbers M.

Malar J. 2012 Oct 26;11:355. doi: 10.1186/1475-2875-11-355.

46.

Pharmacokinetics and pharmacodynamics of oral artesunate monotherapy in patients with uncomplicated Plasmodium falciparum malaria in western Cambodia.

Saunders D, Khemawoot P, Vanachayangkul P, Siripokasupkul R, Bethell D, Tyner S, Se Y, Rutvisuttinunt W, Sriwichai S, Chanthap L, Lin J, Timmermans A, Socheat D, Ringwald P, Noedl H, Smith B, Fukuda M, Teja-Isavadharm P.

Antimicrob Agents Chemother. 2012 Nov;56(11):5484-93. doi: 10.1128/AAC.00044-12. Epub 2012 Aug 6.

47.

Artemisinin-resistant malaria: research challenges, opportunities, and public health implications.

Fairhurst RM, Nayyar GML, Breman JG, Hallett R, Vennerstrom JL, Duong S, Ringwald P, Wellems TE, Plowe CV, Dondorp AM.

Am J Trop Med Hyg. 2012 Aug;87(2):231-241. doi: 10.4269/ajtmh.2012.12-0025. Review.

48.

No evidence for spread of Plasmodium falciparum artemisinin resistance to Savannakhet Province, Southern Laos.

Mayxay M, Khanthavong M, Chanthongthip O, Imwong M, Lee SJ, Stepniewska K, Soonthornsata B, Pongvongsa T, Phompida S, Hongvanthong B, Ringwald P, White NJ, Newton PN.

Am J Trop Med Hyg. 2012 Mar;86(3):403-408. doi: 10.4269/ajtmh.2012.11-0497.

49.

Efficacy of artemether-lumefantrine in area of high malaria endemicity in India and its correlation with blood concentration of lumefantrine.

Valecha N, Mohanty S, Srivastava P, Sharma S, Tyagi P, Bergqvist Y, Ringwald P.

Am J Trop Med Hyg. 2012 Mar;86(3):395-7. doi: 10.4269/ajtmh.2012.11-0182.

50.

The threat of artemisinin-resistant malaria.

Dondorp AM, Fairhurst RM, Slutsker L, Macarthur JR, Breman JG, Guerin PJ, Wellems TE, Ringwald P, Newman RD, Plowe CV.

N Engl J Med. 2011 Sep 22;365(12):1073-5. doi: 10.1056/NEJMp1108322. No abstract available.

Supplemental Content

Loading ...
Support Center